Plasma Cell Leukemia
specificAn aggressive plasma cell neoplasm characterized by the presence of neoplastic plasma cells in the peripheral blood. It is characterized by the presence of a circulating clonal plasma cell count that exceeds 2x10^9/L or is 20% of the leukocyte differential count.
12
Centers
5
Active Trials
—
Cancer Funding
Top Centers for Plasma Cell Leukemia(12)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive High-Volume Research Center | 74.8 |
| 2 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive High-Volume Research Center | 71.0 |
| 3 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 50.4 |
| 4 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive | 50.4 |
| 5 | Duke Cancer InstituteDurham, NC NCI Comprehensive | 50.4 |
| 6 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 50.4 |
| 7 | OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive | 50.4 |
| 8 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | 50.4 |
| 9 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | 50.4 |
| 10 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR | 50.4 |
| 11 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive | 50.4 |
| 12 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 50.4 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →